<?xml version="1.0" encoding="UTF-8"?>
<p>Human hepatitis E is endemic worldwide, particularly in Asia, where large waterborne outbreaks have been reported (
 <xref ref-type="bibr" rid="R1">
  <italic>1</italic>
 </xref>). Seroprevalence of hepatitis E virus (HEV) is &gt;60% in rural southern People’s Republic of China (
 <xref ref-type="bibr" rid="R2">
  <italic>2</italic>
 </xref>) and 4%–10% in western Europe (
 <xref ref-type="bibr" rid="R3">
  <italic>3</italic>
 </xref>) and the United States (
 <xref ref-type="bibr" rid="R4">
  <italic>4</italic>
 </xref>). In these areas, hepatitis E occurs mostly as sporadic cases (
 <xref ref-type="bibr" rid="R5">
  <italic>5</italic>
 </xref>
 <italic>–</italic>
 <xref ref-type="bibr" rid="R7">
  <italic>7</italic>
 </xref>), but epidemics also have been described (
 <xref ref-type="bibr" rid="R8">
  <italic>8</italic>
 </xref>). Most cases in Europe have been linked to genotype 1 (g1) virus and associated with travel to g1-endemic areas. However, autochthonous human infections are increasing in Europe and in other industrialized countries (
 <xref ref-type="bibr" rid="R5">
  <italic>5</italic>
 </xref>
 <italic>,</italic>
 <xref ref-type="bibr" rid="R6">
  <italic>6</italic>
 </xref>
 <italic>,</italic>
 <xref ref-type="bibr" rid="R9">
  <italic>9</italic>
 </xref>). Of the 4 genotypes affecting humans, genotype 3 (g3) is the main HEV genotype also circulating among pigs in Europe (
 <xref ref-type="bibr" rid="R10">
  <italic>10</italic>
 </xref>) and human infections are observed sporadically worldwide (
 <xref ref-type="bibr" rid="R11">
  <italic>11</italic>
 </xref>
 <italic>,</italic>
 <xref ref-type="bibr" rid="R12">
  <italic>12</italic>
 </xref>).
</p>
